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Excitotoxic cell death induces delayed proliferation of
endogenous neuroprogenitor cells in organotypic
slice cultures of the rat spinal cord
GL Mazzone1, M Mladinic1,2,3 and A Nistri*,1,2
The aim of the present report was to investigate whether, in the mammalian spinal cord, cell death induced by transient
excitotoxic stress could trigger activation and proliferation of endogenous neuroprogenitor cells as a potential source of a lesion
repair process and the underlying time course. Because it is difficult to address these issues in vivo, we used a validated model
of spinal injury based on rat organotypic slice cultures that retain the fundamental tissue cytoarchitecture and replicate the main
characteristics of experimental damage to the whole spinal cord. Excitotoxicity evoked by 1 h kainate application produced
delayed neuronal death (40%) peaking after 1 day without further losses or destruction of white matter cells for up to 2 weeks.
After 10 days, cultures released a significantly larger concentration of endogenous glutamate, suggesting functional network
plasticity. Indeed, after 1 week the total number of cells had returned to untreated control level, indicating substantial cell
proliferation. Activation of progenitor cells started early as they spread outside the central area, and persisted for 2 weeks.
Although expression of the neuronal progenitor phenotype was observed at day 3, peaked at 1 week and tapered off at 2 weeks,
very few cells matured to neurons. Astroglia precursors started proliferating later and matured at 2 weeks. These data show
insult-related proliferation of endogenous spinal neuroprogenitors over a relatively brief time course, and delineate a narrow
temporal window for future experimental attempts to drive neuronal maturation and for identifying the factors regulating this
process.
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The majority of new spinal cord injury (SCI) cases show a
mismatch between moderate neuronal cell death and severity
of chronic symptoms like paralysis with sensory and auto-
nomic dysfunction.1,2 As neuronal cell losses are limited,
restorative strategies with stem and progenitor cells are under
investigation for tissue repair and recovery in neonatal and
adult SCI.3–5 Major goals to understand how to repair the
spinal cord tissue are clarification of the duration of the
secondary lesion process and whether certain intrinsic cells
may proliferate to compensate for damage and to obtain
functional improvement.3 One of the early principal contribu-
tors to the lesional process is excitotoxicity due to excessive
release of the excitatory transmitter glutamate6,7 that triggers
a series of complex biochemical processes further amplifying
the damage (secondary lesion).8,9
The adult spinal cord is derived from the caudal neural tube,
which is initially composed of heterogeneous neuroepithelial
cells surrounding a central lumen with distinct proliferative and
differentiation potential.10 Although in a few regions of the
adult mammalian brain, neurogenesis from multipotent
progenitor cells occurs throughout life,11 in the spinal cord
this phenomenon is restricted to the area around the central
canal and is rarely observed in the parenchyma.12 A recent
study has shown that, in the adult mouse spinal cord,
progenitors make up a small population comprising ependymal,
astrocytic and oligodendrocytic lineages.13 The question
then arises about the role that spinal progenitor cells may
have in attempting damage repair after SCI. In the normal
adult mouse, only ependymal cells show stem cell properties
and multineage potential, although none of them is reported to
finally evolve into a neuronal phenotype, as most display an
oligodendrocytic profile.13 In the rat spinal cord, progenitors
can proliferate to neurosphere-forming cells that, when grown
in vitro, they can be transformed into neurons and glia.14
Although stem cells from embryonic and adult nervous
systems appear similar in their differentiation process,15 it is
unclear whether, after experimental SCI, progenitor cells
intrinsic to the spinal tissue can mature to neurons and glia
and replace lost cells. It is difficult to study these questions
with in vivo animal models that allow only limited experimental
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access to the lesion evolution at serial time points after an
acute SCI always produced, for ethical reasons, under
general anesthesia that might partially constrain
damage severity. To partially circumvent these problems,
organotypic spinal cultures, that retain the basic spinal
cytoarchitecture, have been used as an in vitro model of
acute SCI induced by transient excitotoxicity with
consequent moderate loss of neurons, minimal glial damage
and strong impairment in endogenous glutamate release
24 h later.16,17 The short duration of excitotoxic stress is
suggested to mimic the timeframe of clinical injuries usually
treated with minimal delay in intensive care to restore
metabolic dysfunction. The aims of the present study were
to assess: (1) how long cell death continued beyond the first
24 h; (2) whether any intrinsic progenitor cells could proliferate
in response to excitotoxicity; (3) what their fate could be; and
(4) whether they might restore the network ability to release
the main excitatory transmitter glutamate essential for
locomotor network function.18
Results
Endogenous release of glutamate following excitotoxicity.
Previous experiments have indicated that kainate not
only induces delayed excitotoxic cell death but is also a
potent tool to evoke the release of endogenous glutamate
(assessed with a real-time electrochemical assay) that is a
useful, simple index of spinal network activity in culture.19 In
the present study, we compared the glutamate releasing
ability by 100mM kainate on long-term cultures that had been
previously treated with the same kainate concentration
versus naı¨ve cultures (see protocol in Supplementary
Figure S1a). Figure 1a shows that, on average (n¼ 8
cultures), the releasing effect of 100 mM kainate on formerly
(240 h) treated cultures was very large with a time course
characterized by an early peak and a slow decline to
baseline. On the basis of the calibration tests, the peak
current amplitude corresponded to 14.87±5.67 mM extra-
cellular glutamate (P¼ 0.043 versus naı¨ve cultures). In
contrast, average release of glutamate from naive cultures
(n¼ 7) kept for equivalent time in vitro (240 h) was very
similar to the one observed at the normal start of the
experiments (22 days in vitro, DIV) and amounted to an
estimated 3.02±1.47 mM concentration of glutamate. As
these observations suggested spinal network plasticity
(in analogy to the one developing in the human spinal
cord),20 we further investigated the cell population at various
times after the initial excitotoxic stimulus.
Time-dependent distribution of the neuronal loss. In all
three slice regions, kainate significantly increased the
occurrence of pyknotic nuclei (observed with 40,6-diami-
dino-2-phenylindole (DAPI) staining), a process already
detectable at the end of 1 h application of kainate and
intensified 24 h later despite intensive washout.17 Never-
theless, from the peak toxic effect observed 24 h after
washout, the percent of pyknotic cells was gradually reduced
in all three regions over the next 48–72 h (Figures 2a and b,
gray and hatched bars). When pyknotic cells data from the
three regions were pooled, the occurrence of pyknosis at
72 h after excitotoxic stimulation was as low as in the
untreated controls and did not change even at longer time
(336 h) in culture (Figure 2c). Together with the observation
that cell death had stopped by 72 h, there was, unexpectedly,
a rebound in the total number of surviving cells (measured as
non-pyknotic DAPI-positive elements) that was similar to the
value of untreated controls (316±30 versus 344±27,
respectively, n¼ 5 slices for each protocol). Even at 192 h
after kainate, surviving cells were as many as in untreated-
matched cultures (370±29 versus 365±22, respectively;
n¼ 6–7 slices for each protocol).
The number of neurons, identified because of their NeuN
(neuronal-specific nuclear protein) nuclear positivity, fell
24 h after kainate application17 and remained stable
thereafter (Figure 2d). Our data, thus, suggested that the
incidence of neuronal loss in three spinal regions did not
increase beyond 24 h as the number of surviving neurons
remained constantly low. Nevertheless, because of the
global number of cells eventually became similar to the one
in control conditions, it seemed likely that excitotoxicity had
elicited delayed cell proliferation in response to the initial
damage.
Figure 1 Glutamate release induced by kainate (KA) application on long-term
cultures. (a) Average profile of endogenous glutamate release from slices exposed
to 100mM kainate (applied within arrows) in control condition (treated only once at
32 DIV; black trace; n¼ 7) and after a second KA application after the former KA
treatment (KAþKA; gray trace; n¼ 8). The ordinate shows the redox current
continuously monitored throughout the experiment with the glutamate biosensor in
basic solution. Note the strong current response from on long-term cultures that had
been previously treated (KAþ KA) versus control cultures. (b) Histograms showing
the mean peak current obtained for different slices following KA application for 1 h at
22 DIV (n¼ 4) and at 32 DIV in KAþ KA (n¼ 8) or control condition (n¼ 7).
*Po0.05 versus controls
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Cell proliferation induced by kainate. This phenomenon
was estimated by counting the number of Ki67 (proliferation
marker antigen Ki67) positive nuclei, a validated marker
expressed during all phases of the cell cycle (G1, S, G2
and M, and absent in G0).21 Figures 3a and b demonstrates
that, 72 h after kainate, a significant increase in the number
of Ki67-positive nuclei appeared in the three spinal regions.
To further evaluate the number of dividing cells, we
used the assay based on 5-ethynyl-20-deoxyuridine (EdU)
incorporation into the DNA (see Materials and Methods).
EdU was applied simultaneously with kainate (or to sham
cultures) and maintained in culture for the following 24 h
(see protocol scheme in Supplementary Figure S2a).
In untreated controls at 72 h, only a few EdU-positive
cells were observed (Figure 3c) and were localized to the
region of the ventral fissure. At the same time point
(Figure 3d), kainate treatment significantly increased the
number of EdU-positive cells (over the global DAPI-positive
population) that had a scattered distribution (Figure 3c,
right). One week later (192 h), EdU-positive cells were
even more numerous particularly after kainate treatment
(Figure 3d).Validation of these results was obtained by
observing also bromodeoxyuridine (BrdU) incorporation into
the DNA of dividing cells (see protocol in Supplementary
Figure S2b) at 72 h in analogy with the data obtained
with the EdU method (Figure 3e). Globally, these results
suggest that transient kainate application enhanced
delayed and sustained cell proliferation in the spinal cord
organotypic culture and prompted us to characterize the
new cell types.
Glial phenotypes observed after kainate treatment.
Figure 4a (left) and b shows that, at 72 h, in control
conditions nearly half of the relatively small number of
EdU-positive cells were also S100 (astroglial calcium-binding
protein S100B) positive, a cytoplasmic Ca2þ binding protein
strongly expressed by astrocytes.22 Seventy-two hours after
kainate treatment (Figure 4a (right) and b), despite the larger
number of EdU-positive cells, the number of astrocytes that
were EdU-positive remained as low as control (see also
Figure 4b). Although a significant increase in S100 cyto-
plasmic immunoreactivity signal was observed 72 h after
kainate (Figure 4d), no change was detected in immunor-
eactivity for vimentin (Supplementary Figures S3a and b)
used as a marker for progenitor cells.23 When glutamine
synthetase (GS), a standard cytoplasmic marker for astro-
cytes in the brain and spinal cord,24,25 was analyzed, no
statistically significant change in immunoreactivity was
observed 72 h after kainate (Supplementary Figures S3c
and d). Two weeks after kainate (336 h), the number of
EdU-positive cells that co-expressed S100 (Figures 4a and c)
significantly grew with respect to sham controls, indicating
delayed proliferation of S100-positive cells, whereas the
S100 immunoreactivity signal was analogous to untreated
controls (Figure 4e). This observations support the dissocia-
tion between the number of lately proliferating astrocytes and
the S100 signal strength.
Using Iba1 (ionized calcium-binding adapter molecule 1) as
biomarker for microglia,26 there was no significant change in the
number of Iba1-positive cells after 72 h from kainate washout,
as they remained a rather small fraction of the slice population22
Figure 2 Cell losses evoked by kainate in long-term cultures. (a) Examples of DAPI nuclear staining for the central region in control condition, or after 24 or 72 h washout of
kainate (KA; 100mM for 1 h). White dots indicate pyknotic nuclei. (b) Increased occurrence of cells with pyknotic nucleus after KA application in three slice regions, with
maximum effect after 24 h and a gradual reduction over the next 48–72 h (n¼ 8–14 slices, from seven different experiments). Data are referred to the total number of
DAPI-stained cells. (c) Plots showing the mean percent value for pyknotic cells in cryostat-cut sections during washout after KA application (n¼ 5–7 slices, from at least three
different experiments). (d) Histograms showing the number of NeuN-positive cells counted before KA application (control) and 24, 48 and 72 h after kainate washout in three
slice regions (n¼ 5–6 slices, from at least four different experiments). *Po0.05 versus controls
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as shown in Figures 5a and b. However, we observed a
morphological change in microglia 24 h after kainate because a
significant increase in the number of microglial branches and
endpoints was observed (Figures 5c and d).27
Neuronal phenotype after kainate treatment. Developing
neurons are typically identified by the biomarker double
courting (DCX), a cytoplasmic protein that regulates micro-
tubule dynamics and processes involved in neuronal migra-
tion and fiber outgrowth, and that first appears at 10.5
embryonic day.28 Once neuronal migration and maturation
are complete, DCX expression is strongly reduced and
neurons are conventionally identified by the nuclear marker
NeuN.29 At 72, 192 and 336 h after kainate (Figures 6a–d), a
minority of EdU-positive cells also expressed DCX, reaching
a maximum at 192 h, and tapering off at 336 h (Figures 6b–d).
At the time (192 h) of the largest expression of DCX-positive
cells, the average number of neurons was 170±13 in control
and 84±10 after kainate (n¼ 8 slices), that is, values similar
to those found at 24–72 h (Figure 2), suggesting that there
had been no concomitant change in the global neuronal
population. Thus, after the excitotoxic stimulus, a few
proliferating progenitor cells showed their potential to mature
into neurons within a limited time window.
To measure how many neuronal progenitors actually
became neurons, we examined the number of NeuN-positive
cells also stained for EdU. As shown in Figure 7, at 72 h,
although the number of new cells was significantly higher
following kainate application than in control (Figures 7a and b),
the number of new neurons was very small and similar to
control. At 336 h after kainate, although the number of new
cells had increased (Figures 7a and c) when compared with
the value observed at 72 h, the average number of new
neurons remained, however, very small. In fact, at 336 h the
global number of neurons was 98±10 after kainate versus
139±10 in matched untreated controls (n¼ 7). Hence, the
simplest interpretation of these data was that most DCX-positive
cells had failed to mature into neurons despite continuous cell
proliferation even after 2 weeks from kainate treatment.
Discussion
The present report shows that organotypic cultures of the rat
spinal cord, that are a useful model to study cell death after
excitotoxicity,17 manifested delayed proliferation of neuropro-
genitors into astroglia, and their failure to generate new
neurons. These results suggest that future experimental
attempts to stimulate maturation of endogenous progenitors
into neurons should be concentrated to a narrow time window
after the acute lesion.
Delayed effects of spinal cord damage. Studying the time
course of early effects originating after SCI is a complex task
because in vivo animal experiments are usually unsuitable
Figure 3 Cell proliferation induced by kainate on long-term cultures. (a) Examples of Ki67 staining (red) and DAPI-positive cells (blue) in the central region 72 h after
kainate application. (b) Histograms showing the percent value of Ki67-positive cells over total number of cells. Ki67-positive cells were significantly increased in all three spinal
cord regions (n¼ 8–10 slices, from four different experiments, *Po0.05 versus control). (c) Representative EdU-stained cells (green) in control condition (left). Hoechst-
positive cells are shown in blue. Note clustering of EdU-positive cells at the central fissure. Right, 72 h after kainate application (KA; 100mM for 1 h), EdU-positive cells show
scattered distribution. (d) Histograms show the percent number of EdU-positive cells over total number of cells after 72 h kainate wash or control (n¼ 5 slices, from two
different experiments, *P¼ 0.0016 versus control at 72 h; *P¼ 0.008 versus control at 192 h). (e) Histograms show the percent number of BrdU-positive cells over total
number of cells after 72 h of kainate washout (n¼ 3–5 slices, from two different experiments, *Po0.05 versus control)
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for repeated neuropathological sampling, and isolated spinal
cord preparations survive in vitro for up to 24 h only.30
Excitotoxicity of organotypic cultures of the rat spinal cord17
closely mimics the main pathophysiology of the rat spinal
cord in vivo during the first few hours after SCI31 and triggers
neuronal death via a process termed parthanatos.32 Of
course, this is a simplified system that lacks blood supply
(and, thus, blood-borne substances) and immunological
reactions, which are important processes in vivo.33 The low
number of microglial cells remained unchanged and was
associated with their enhanced ramification34 that is a
dynamic process observed early after brain injury,35 and
attributed to targeted phagocytosis.27
Cell proliferation after kainate excitotoxicity. We investi-
gated how the organotypic culture cell population changed
after the first day following transient excitotoxicity, which is
known to affect primarily neurons and to spare glia.16,17
Notwithstanding the region-specific number of neurons,22 the
neuronal damage evoked by kainate was proportionally
uniform, completed within 24 h, and remained stable during
the subsequent days and weeks. Cell death was therefore
minimal at longer intervals. The initial damage was, however,
sensed by the in vitro network that, via cell proliferation,
re-established, after 1 week, the global number of cells as
observed in sham controls.
To seek further evidence for cell proliferation, we counted
the number of Ki67-positive elements because this biomarker
is a sensitive tool to evaluate progenitor cells that can evolve
into neurons or glia.36 Ki67-labeled cells were always a clear
minority (o10%) of the global cell population, but they were
comparatively more numerous (two or three times more in all
Figure 4 Glial cell proliferation after kainate treatment. (a) Examples of images showing EdU (green), S100 (red) and Hoechst-positive (blue) cells after 72 or 336 h
washout of kainate. (b and c) Histograms indicate the number of EdU-positive cells that also are stained for S100 at 72 h (b, n¼ 3 slices, from two different experiments,
*P¼ 0.031 versus control) or 336 h (c, n¼ 5 slices, from two different experiments, *Po0.05 versus control) after kainate or in control condition. Note delayed glial
proliferation indicated by late increment in EdU-positive and S100-stained cells. (d and e) Histograms show increase in S100 mean fluorescence intensity (arbitrary unit, AU),
expressed as percent of control, at 72 h (d, n¼ 3–6 slices, from two different experiments, *P¼ 0.003 versus control) or 336 h (e, n¼ 5 slices, from two different experiments)
after kainate. Note increased S100 signal in KA-treated slices at 72 h but not 336 h after kainate
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spinal areas) 72 h after kainate. We next assessed Ki76 cells
proliferation by analyzing the incorporation of selective DNA
biomarkers (EdU or BrdU) (http://www.sendcockpit.com). In
control conditions, EdU-positive cells were particularly found
near the central fissure that corresponds anatomically to the
region around the spinal central canal, from where they
spread out after injury. Hence, the simplest interpretation is
that an experimental lesion had triggered activation and
proliferation of cell precursors intrinsic to the spinal tissue. The
next question was their fate.
Astroglia proliferation. The in vivo rat SCI model results in
astrogliosis, neuronal and oligodendroglial cell death, axonal
degeneration and demyelination that collectively lead to
significant spinal cord tissue loss and consequently the
formation of a central cavity at the chronic stage of injury
(i.e., around 4 weeks or more after SCI).8,37 Our focus was to
find out how intrinsic cells reacted over a critical, earlier stage
of SCI with a view of devising future experimental approaches
to hinder the pathological process progression. GS has also
been implicated as a hallmark of reactive astrocytosis, by its
critical role in the glutamate catabolism following SCI.25
However, no difference in GS immunostaining 72 h after
kainate was observed in the present study, even if GS is
suggested to be involved in the endogenous mechanism of
protection against neurotoxicity after SCI in vivo.25 The
persistence of the GS immunoreactivity confirms our
previous studies30,32 that excitotoxicity primarily damages
Figure 5 Examples of immmunohistochemical staining showing Iba1 (a, red) and DAPI-positive (blue) cells 72 h after washout of kainate or in control. (b) Histograms
showing the average number of Iba1-positive cells counted before kainate application (control) or 72 h after kainate wash. Note the relative low number of Iba1-positive cells
(in accordance with our former study22). Morphological characterization of microglia was done with the skeleton method.27 (c) Quantification of Iba1 morphology shows
increase in the number of branches and end points, without alteration of the maximum branch length (*Po0.05 versus control)
Figure 6 DCX-expressing cells indicate potential neurogenesis after kainate application. (a) Examples of EdU (green), DCX (red) and Hoechst-positive (blue)
cells after kainate application and 336 h wash. (b–d) Histograms showing the number of DCX-positive cells over the total EdU-positive nuclei found at 72
(b, n¼ 3 slices, from two different experiments, *Po0.05 versus control), 192 h (c, n¼ 3 slices, from two different experiments, *Po0.05 versus control) or 336 h
(d, n¼ 4 slices, from two different experiments, *Po0.05 versus control). Note increased number of DCX-positive cells in KA-treated slices as compared with control at
each time point
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neurons rather than glia in the rat spinal cord. Our current
results showing a transient, early increase in the S100 signal
accord with recent clinical data that underlie the importance
of high serum S100 levels as a biomarker of brain lesions
affecting astroglia.38
To further investigate the contribution by astroglia to
excitotoxicity following kainate administration, we found
EdU-positive cells with S100 immunoreactivity suggestive
of astroglia proliferation only after 2 weeks in culture.
Interestingly, despite the lack of early association between
S100 and EdU staining and no early increase in immuno-
reactivity for the precursor marker vimentin, the strength of
the S100 fluorescence signal was enhanced 3 days after
kainate. As recently reviewed,38 there is ample evidence for
the role of S100 in brain injury, whereby this protein not
simply leaks out from damaged cells, but it is actively
secreted in response to damage so that its detection in
biological fluids makes it a biomarker for active cell injury in
the nervous system. In the current study, the simplest
explanation is that glial cells reacted with stronger expres-
sion of S100 before their progenitor proliferation. A late
increase in glial cells likely contributed to the recovery in cell
numbers observed after 1 week from the initial kainate
application.
Neuronal progenitors. DCX-immunoreactive neuronal pre-
cursors started proliferating already at 72 h from the
excitotoxic stress and reached a maximum at 192 h, after
which their number decreased. These observations differ
from a recent study of sustained (24 h) excitotoxic injury to
rat organotypic hippocampal slices, where cell death
continued for up to 7 days, astroglial proliferation was lacking
and DCX expression increased, although the actual number
of surviving neurons was not reported.39
The present investigation shows that most DCX-positive
precursors failed to mature into neurons, so that this process
was inadequate to recreate the original neuronal number. This
finding accords with studies of long-term survival of brain
neurons as about 80% of the stroke-generated new striatal
neurons die during the first 2 weeks after their formation.40
This result is probably due to the deleterious pathological
environment surrounding the new neurons41 in vivo as much
as in vitro. In brain networks, kainate evokes neuronal death
followed by plasticity rearrangement with delayed onset of
spontaneous seizures.42 Enhanced network excitability is
reported after SCI even in areas remote from the primary
lesion.43 This phenomenon is compatible with the large
increase in glutamate release we detected long after kainate
treatment. Although future studies are necessary to identify
the precise mechanisms underlying the facilitated release of
glutamate, this process probably originated from the reverse
operation of glutamate carriers on glial and neuronal
membranes as described after SCI in vivo44,45 and it may be
correlated to hyperexcitability of glutamatergic networks
during the secondary phase of SCI.20,46,47
Conclusions
As acute SCI results in rapid loss of neurons within the first
day,9,48 network reconstruction through cell replacement is
an attractive target to produce functional recovery.49,50
Although much work is focussed on transplanted stem cells
especially as a major source of factors promoting recovery
after SCI,51,52 little is known about their role of endogenous
stem cells after SCI.3 The present report suggests that,
after excitotoxic damage, progenitor cells could proliferate
for a limited time only and most failed to mature into neurons.
This observation delineates a time window for exploring
how to drive their full maturation and, thus, provides a
convenient test system for experimenting genomic or
proteomic approaches to improve the outcome of progenitor
cell treatment.
Figure 7 Lack of neuronal progenitor maturation after kainate. (a) Representative NeuN (red), EdU (green) and Hoechst-positive (blue) cells in control condition or after
kainate application followed by 72 or 336 h washout. (b and c) Histograms showing the number of EdU-positive cells with or without NeuN labeling at 72 h (b, n¼ 3 slices, from
two different experiments, *P¼ 0.001 versus control) and 336 h (c, n¼ 5–6 slices, from two different experiments, *P¼ 0.017 versus control). Note that the number of new
neurons was very small and similar to control after 72 or 336 h washout
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Materials and Methods
Preparation and maintenance of organotypic cultures. Spinal cord
organotypic slices were prepared from embryos (at 13 days of gestation) of
pregnant Wistar rats as previously reported.17,53 Briefly, the fetuses were delivered
by caesarian section from timed-pregnant rats killed by slowly raising levels
of CO2. Approval for these experiments was obtained from the Scuola
Internazionale Superiore di Studi Avanzati (Trieste, Italy) Ethical Committee. All
efforts were made to reduce the number of animals used and to minimize animal
suffering.
Culture slices were grown in a medium containing 82% Dulbecco’s Modified
Eagle medium (DME/HIGH (Dulbecco’s modified Eagle’s medium high glucose);
osmolarity 300 mOsm, pH 7.35, ‘complete medium’), 8% sterile water for tissue
culture, 10% fetal bovine serum (FBS; Invitrogen, Milano, Italy), 5 ng/ml nerve
growth factor (NGF; Alomone Laboratories; Jerusalem, Israel) and maintained in
culture for 22 DIV in accordance with standard procedures.54,55 DME/HIGH,
penicillin and streptomycin were purchased from Euroclone (Paignton, UK). Fetal
calf serum (FCS) was obtained from Invitrogen. Unless otherwise indicated, other
reagents were purchased from Sigma-Aldrich, Milan, Italy.
Protocol for excitotoxic injury on organotypic cultures. Supple-
mentary Figures S1 and S2 summarize the experimental protocols used for the
current study. Acute excitotoxicity injury was produced, at 22 DIV, by applying
kainate for 1 h (100mM; Ascent Scientific, Bristol, UK) dissolved in complete
culture medium and then carefully washed out with complete medium. Following
kainate washout, cultures were used for electrochemical experiments
(Supplementary Figure S1a) and/or immunohistochemistry studies (Supplementary
Figure S1b). Control preparations (sham) were, in each experiment, untreated sister
cultures maintained in vitro for the same time points and subjected to the same
medium washout.
Electrochemical glutamate release. In accordance with our previous
report,19 the release of glutamate was measured by using electrochemical
biosensors (Sarissa Biomedical Ltd, Coventry, UK). On-line records were
integrated with a potentiostat (Pinnacle Technology Inc., Lawrence, KS, USA)
and analyzed off-line with PAL software (V1.5.0; Pinnacle Technology Inc.). We
used glutamate and null biosensors (for specific and non-specific electroactive
measurements) that were placed at each side of the ventral fissure. The specificity
of the glutamate sensor was validated by using a glutamate calibration curve
(0.5–50mM) and a single point calibration (with 50 mM) was repeated at the end of
each experimental day. Glutamate release was recorded using a basic solution
(containing in mM: NaCl, 152; KCl, 5; CaCl2, 2; MgCl2, 1; HEPES, 10; glucose, 10,
pH 7.4; 300–320 mOsm; Sigma-Aldrich, Milan, Italy). The basal glutamate release
value was obtained after stabilizing the sensor on the slice for a few minute.
Supplementary Figure S1a summarizes the experimental protocol used for this
study. The redox current related to glutamate release was induced by kainate
(100mM for 1 h) in control slices (at 32 DIV) or slices (at 32 DIV) that had received
the first application of kainate at 22 DIV.
Organotypic slice immunostaining and cell counting. As
previously described,22 cultures were fixed in 4% paraformaldehyde for 60 min
at room temperature and stored in phosphate-buffered saline (PBS) until use or in
30% sucrose PBS for cryoprotection (24 h at 4 1C). Cryoprotective slices
were cryostat-sectioned to obtain, on average, 6–8 tissue sections (16 mm thick)
from each organotypic culture, which were collected sequentially on histology
slides.
Immunohistochemistry experiments were performed in accordance with previous
reports.17,22 Slices were blocked with 3% FCS, 3% bovine serum albumin (BSA),
0.3% Triton in PBS (blocking solution) for 1 h at room temperature, followed by
overnight incubation at 4 1C in a blocking solution containing the previously
validated primary antibodies using the following dilutions: NeuN (1:250; Millipore,
Billerica, MA, USA), Ki67 (1:100; Abcam, Cambridge, UK), Iba1 (1:750; Wako,
Osaka, Japan), vimentin (1:200, Abcam), GS (1:300, Millipore); S100 (1:1000;
Dako, Glostrup, Denmark), BrdU (1:100, Sigma) and DCX (1:100, Santa Cruz
Biotechnology, Heidelberg, Germany; and 1:1000, Abcam). The primary antibody
was visualized using a secondary fluorescent antibody (Alexa Fluor 488 or 594 at
1:500 dilution; Invitrogen, Carlsbad, CA, USA). To visualize cell nuclei, slices were
incubated with 40, 6-diamidino-2-phenylindole (DAPI, 1 mg/ml; Sigma) or Hoechst
33342, (5 mg/ml; Invitrogen, Milano, Italy) and mounted using a fluorescence
mounting medium (DAKO, Milan, Italy).
For each slice culture, the number of NeuN-positive cells was obtained by
counting stacks of 25–30 images with a confocal microscope as previously
described,17 and also by analyzing the cryostat tissue sections using a Zeiss
Axioskop2 microscope. In both cases, the total number of NeuN-positive cells was
quantified with ‘eCELLence’ software (Glance Vision Tech, Trieste, Italy) giving
similar results as previously described.22 The number of Iba1-positive cells was
analyzed using confocal microscopy, whereby a stack of five images
( 40 magnification) were counted with ‘eCELLence’ as previously described.22
The morphology of Iba1-positive cells was analyzed by the ‘skeleton’ method.27
Thus, the signal from Iba1-positive processes was enhanced to optimize their
detection followed by noise de-speckling to eliminate background fluorescence. The
resulting images were converted to binary data and then ‘skeletonized’ by using
Image J software (version 1.44p c; Wayne Rasband, National Institutes of Health,
Bethesda, MD, USA) as exemplified in Figure 5c. The AnalyzeSkeleton plugin
(http://imagejdocu.tudor.lu/doku.php?id=plugin:analysis:analyzeskeleton:start) was
then applied to such images to collect data on the number of branches, end points
and process lengths.
The vimentin and S100 biomarker signals were collected as mean fluorescence
intensity with densitometry analysis using a Zeiss Axioskop2 microscope and
MetaVue software (Molecular Devices, Sunnyvale, CA, USA).
DAPI nuclear staining was used to identify the dead/dying cells quantified with
‘eCELLence’ software in three different regions of interest (r.o.i.), namely dorsal,
central and ventral, as previously reported.17 The average percent values of nuclei
with condensed chromatin were compared between different r.o.i. for control- or
kainate-treated slices and normalized to the total number of nuclei.
Proliferation assay–BrdU, EdU and Ki67 staining. Various
methods36 were used for assaying cell proliferation. In particular, the recently
reported Click iT EdU technique, especially advantageous because it does not
require denaturing DNA or the use of antibodies, was used in accordance with the
manufacturers’ instructions (Invitrogen, http://products.invitrogen.com/ivgn/product/
E10187). Furthermore, we used an antibody against BrdU that binds to DNA or
against the cell cycle antigen Ki67, a nuclear protein expressed by proliferating
cells in G1, S, G2 and M (but not in G0) phases.21 Supplementary Figure S2a
summarizes the experimental protocol. Slices were treated with a solution
containing kainate (100mM) and EdU (10mM) or BrdU (50 mM) for 1 h; after this
incubation time, slices were maintained in complete medium containing only EdU
or BrdU for the following 24 h, and then washed. Sham slices were processed in
the same way except that kainate application was omitted. After fixation,
cryopreservation and cryostat sectioning, incorporated EdU was detected with the
fluorescentazide coupling reaction, whereby cells were incubated for 30 min with
azide-conjugated Alexa Fluorophor in a reaction cocktail supplemented with
CuSO4 (100 mM). Cells were then washed two times with 3% BSA in PBS and
nuclear-stained with Hoechst 33342 (5 mg/ml) for 30 min at room temperature, and
finally slide-mounted using a fluorescence medium (DAKO). The counting of EdU-
positive cells was done using a Zeiss Axioskop2 microscope and MetaVue
software and was quantified using ‘eCELLence’ software. The estimation of EdU-
positive cells, and the percentage of cells that were positive also for S100, DCX
and NeuN markers, was done by counting manually with Image J software.
For BrdU quantification,56 cryostat-sectioned slices were sequentially incubated
with 0.01 M citrate buffer (15 min at 90 1C), 2 N HCl (10 min at 37 1C), neutralized by
immersing them in 0.1 M borate buffer (twice for 5 min at room temperature) and
washed twice in 0.1% PBS-Tween-20. After this procedure, slices were processed
for immunostaining with the BrdU antibody. To verify the optimal concentration
and the staining procedure, we used a neuroblastoma-spinal cord subclone 34
(NSC-34) cell line, which is a hybrid cell line produced by the fusion of motor neuron-
enriched embryonic mouse spinal cord cells with mouse neuroblastoma cells,57
kindly donated by Dr. Silvia Di Angelantonio, University of Rome. A linear relation
between the number of plated cells (counted with Counting Chamber Thoma,
Vetrotecnica, Padova, Italy) and the BrdU (50 mM) labeled cells after 72 h was
observed (Supplementary Figure S2b). Counting of BrdU-positive cells was
performed automatically, using Volocity software (PerkinElmer Inc., Waltham, MA,
USA), and manually counted using Image J software.
Statistics. Data were expressed as means±S.E.M; n refers to the number of
organotypic cultures slices. Statistical calculations were done using SigmaStat
3.11 (Systat Software, Chicago, IL, USA). For multiple comparisons the analysis of
variance (ANOVA) test for parametric data followed by the Tukey-Kramer post hoc
test was used. Non-parametric values were analyzed with the Kruskal–Wallis test.
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When two groups were compared, the Student’s t-test for parametric data or the
Mann–Whitney Rank Sum test for non-parametric data was applied. The accepted
level of significance was always Pr0.05.
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